Cancer nanotherapeutic (Ovensa)

N/A

Report date: 2024/02/06 17:54:43

NME

Base Information

Drug NameCancer nanotherapeutic (Ovensa)

Drug Alias NameTRIOZAN™/siRNA Gal-1

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionGalectin-1 inhibitorsRNA interference

TargetsGalectin-1

Therapy Area/IndicationsHead and Neck Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOvensa Inc

China Registration ClassN/A

Active CompaniesOvensa Inc

Inactive CompaniesN/A

Active IndicationsHead and Neck Neoplasms

Inactive IndicationsN/A

ATC CodeN/A